Cart
sales@molnova.com
LY2183240
CAS No. 874902-19-9
LY2183240( —— )
Catalog No. M24889 CAS No. 874902-19-9
LY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). LY2183240 is a novel and highly effective blocker of anandamide uptake (IC50 = 270 pM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 35 | In Stock |
|
| 10MG | 58 | In Stock |
|
| 25MG | 120 | In Stock |
|
| 50MG | 228 | In Stock |
|
| 100MG | 356 | In Stock |
|
| 500MG | 836 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLY2183240
-
NoteResearch use only, not for human use.
-
Brief DescriptionLY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). LY2183240 is a novel and highly effective blocker of anandamide uptake (IC50 = 270 pM).
-
DescriptionLY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). LY2183240 is a novel and highly effective blocker of anandamide uptake (IC50 = 270 pM).
-
In Vitro——
-
In VivoLY2183240 (3-30mg/kg; i.p.) dose-dependently attenuates formalin-induced paw-licking pain behavior in the formalin model of persistent pain mechanisms. Animal Model:Male Sprague-Dawley rats (Formalin Pain Model)Dosage:3, 10, 30 mg/kg Administration:I.p.Result:Dose-dependently attenuated formalin-induced paw-licking pain behavior in the formalin model of persistent pain mechanisms.
-
Synonyms——
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorAutophagy|FAAH
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number874902-19-9
-
Formula Weight307.35
-
Molecular FormulaC17H17N5O
-
Purity>98% (HPLC)
-
SolubilityDMSO:50 mg/mL (162.68 mM; Need ultrasonic)
-
SMILESO=C(N(C)C)N1N=NN=C1CC(C=C2)=CC=C2C3=CC=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dickason-Chesterfield AK, et al. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors. Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):407-23.
molnova catalog
related products
-
Mefloquine hydrochlo...
A quinoline antimalarial drug that is structurally related to the antiarrhythmic agent quinidine; inhibits autophagy and has been recognized as a potential target for cancer therapy.
-
LYN-1604 2HCl 221675...
LYN-1604 is a novel ULK1 activator.It inducing cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis.?LYN-1604, to be the best candidate for a ULK1 agonist.?LYN-1604 induced cell death involved in ATF3, RAD21, and caspase3, accompanied by autophagy and apoptosis.?LYN-1604 has potential for good therapeutic effects on TNBC by targeting ULK1-modulated cell death in vivo.
-
O4I1
O4I1 is an effective Oct3/4 inducer.
